Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (66)

« Back to Publications

Permissive central tolerance plus defective peripheral checkpoints license pathogenic memory B cells in CASPR2-antibody encephalitis.

Sun B. et al, (2025), Sci Adv, 11

Permissive central tolerance plus defective peripheral checkpoints licence pathogenic memory B cells in CASPR2-antibody encephalitis.

Sun B. et al, (2025)

esource for extracellular vesicles from activated CD4 T cells that relay pro-inflammatory signals

Jainarayanan AK. et al, (2024)

Ro60-Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases.

Mahla RS. et al, (2024), Int J Mol Sci, 25

Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection.

Mader K. and Dustin LB., (2024), Antibodies (Basel), 13

COVID-19 vaccination and autoimmunity: Do we need more evidence?

Mahla RS. and Dustin LB., (2024), J Med Virol, 96

Impaired central tolerance characterises the early emergence of pathogenic aquaporin 4-specific B cells in neuromyelitis optica spectrum disorder

Ramanathan S. et al, (2024), MULTIPLE SCLEROSIS JOURNAL, 30, 70 - 71

Lessons from a large-scale COVID-19 vaccine trial.

Mahla RS. and Dustin LB., (2022), J Clin Invest, 132

Searching for escape-resistant anti-SARS-CoV-2 neutralizing antibodies.

Mahla RS. and Dustin LB., (2022), J Clin Invest, 132

TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease.

Jones EL. et al, (2021), Front Immunol, 12

n HCV Vaccine on the Fly.

Laidlaw SM. and Dustin LB., (2020), J Infect Dis, 221, 1216 - 1218

Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.

Laidlaw SM. et al, (2017), Gastroenterology, 153, 566 - 578.e5

Innate and Adaptive Immune Responses in Chronic HCV Infection.

Dustin LB., (2017), Curr Drug Targets, 18, 826 - 843

Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.

Dustin LB. et al, (2016), Clin Microbiol Infect, 22, 826 - 832

MAIT cells are activated during human viral infections.

van Wilgenburg B. et al, (2016), Nat Commun, 7

Load More

1
2
3
4
5